Synergistic role of gut-microbial L-ornithine in enhancing ustekinumab efficacy for Crohn’s disease
Zhenyu Wang(Henan Provincial People's Hospital), Jie Hong(Shanghai Jiao Tong University), Yilu Zhou(Shanghai Jiao Tong University), Baoqin Xuan(Shanghai Jiao Tong University), Nan Shen(China-Japan Friendship Hospital), Xuejie Chen(Central South University), Jinmei Ding(Shanghai Jiao Tong University), Xiaoqiang Zhu(Shanghai Jiao Tong University), Yi Jiang(Renji Hospital), Haoyan Chen(Shanghai Jiao Tong University), Zhijun Cao(Seqirus (United States)), Lijun Ning(Shanghai Institute of Hematology), Xiaowen Huang(Renji Hospital), Xiaoyan Wang(Zhejiang Sci-Tech University), Ying Zhao(Shanghai Jiao Tong University), Yanru Ma(Renji Hospital), Tian Li(Xuzhou Central Hospital), Muni Hu(Shanghai Jiao Tong University), Jing‐Yuan Fang(Shanghai Institute of Hematology)
Cited by 30
Related Papers
Comprehensive review of targeted therapy for colorectal cancer
|Signal Transduction and Targeted Therapy|2020|1.7k
A protocol for isolation and culture of mesenchymal stem cells from mouse compact bone
|Nature Protocols|2010|651
Low-dose interleukin-2 treatment selectively modulates CD4+ T cell subsets in patients with systemic lupus erythematosus
|Nature Medicine|2016|570
LncRNA GLCC1 promotes colorectal carcinogenesis and glucose metabolism by stabilizing c-Myc
|Nature Communications|2019|427
Microbiome and metabolome features in inflammatory bowel disease via multi-omics integration analyses across cohorts
|Nature Communications|2023|231